Startups restructure executive roles

Corina Schaer is the new Chief Product Officer at Leg&Airy, the startup revolutionizing the field of orthopedic aids using state-of-the-art 3D printing and scanning technology combined with its design to create custom-made orthoses. Corina brings a unique blend of clinical research and biomedical engineering expertise, along with a fervent passion for integrating state-of-the-art technology into our products. Her ability to fuse cutting-edge technology with human-centric design is exactly what makes her the right leader for this role.

STALICLA welcomes CMO
Thomas Blaettler, a board-certified neurologist with over 30 years of experience in neuroscience, both in clinical residency and within the pharmaceutical industry, has joined STALICLA, a Swiss clinical-stage biopharmaceutical company, pioneering precision treatment in neurodevelopmental and neuropsychiatric disorders. He will help progress their ambitions in CNS conditions. With a strong background in clinical research and a desire to advance treatments for patients in need, Blaettler has held roles with increasing strategic responsibility, overseeing global clinical development programs from Phase 1 to Phase 3. He has profound regulatory experience across various regions and has been instrumental in establishing clinical development and regulatory organizations, as well as successful IPOs at the Copenhagen and New York Nasdaq stock exchanges.

Drone Control welcomes new co-founder and CTO
DroneControl, provider of peer-to-peer encrypted live-streaming and remote control drone software designed for emergency services, announced the appointment of Ross Feehan as Chief Technology Officer (CTO) and Co-founder. Ross brings a wealth of experience, having held several senior roles in both start-up and blue-chip companies. His experience with a focus on Android and full-stack development, as well as his strategic leadership, will be key assets to the leadership team. Ross takes over from Jernej Jerin, the startup’s former co-founder and CTO, who will now focus on the engineering side of the business.

Spiden appoints Jennifer Ireland as CFO
Jennifer Ireland, a former medical doctor with over 15 years of clinical experience, has joined the Spiden team as an investor, bringing a wealth of knowledge and expertise in chronic disease, aging, and the biopsychosocial model of healthcare. Her deep understanding of these complex issues, combined with her experience as an investor at Baillie Gifford, where she identified and supported exceptional public companies, makes her a valuable addition to our team. Her perspective and skills will contribute to Spiden’s mission of driving innovation and growth in the healthcare sector. Spiden is developing a platform for real-time biomarker and drug monitoring using advanced spectroscopy techniques.

Spencer Cabildo succeeds Jeremy Henrichs at NALA
NALA.Care is digitizing the current eczema therapy guideline by offering a 24/7 digital health companion via a mobile app for patients and parents suffering from eczema, a chronic skin condition affecting over 300 million people worldwide. The co-founders of Nala, Jeremy Henrichs and Spencer Cabildo, built the startup from the idea to launch, attracting almost 10,000 eczema patients and securing B2B partnerships with companies such as L'Oréal, Bayer, CSS and more. Jeremy has now handed over his CEO role to Spencer to lead the company into the scale-up phase.

(RAN)